This chapter comprehensively explores the pivotal role of artificial intelligence (AI) in drug
discovery and development, encapsulating its potentials, methodologies, real-world …

Background Psoriasis is a chronic immune-mediated inflammatory systemic disease with
skin manifestations characterized by erythematous, scaly, itchy and/or painful plaques …

Treating retinal diseases to prevent sight loss is an increasingly important challenge. Thanks
to the configuration of the eye, the retina can be examined relatively easily in situ. Owing to …

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity that …

Background Chronic spontaneous urticaria (CSU) is a rare, heterogeneous, severely
debilitating, and often poorly controlled skin disease resulting in an itchy eruption which can …

Abstract Background Lisdexamfetamine (LDX) and Methylphenidate (MPH) are stimulant
agents that have been shown to provide significant benefits in the management of attention …

Computer-aided drug design (CADD) techniques allow the identification of compounds
capable of modulating protein functions in pathogenesis-related pathways, which is a …

Oncology treatments require continuous individual adjustment based on the measurement
of multiple clinical parameters. Prediction tools exploiting the patterns present in the clinical …

Modeling and simulation (M&S), including in silico (clinical) trials, helps accelerate drug
research and development and reduce costs and have coined the term “model-informed …

Introduction Attention-deficit/hyperactivity disorder (ADHD) is an impairing psychiatric
condition with the stimulants, lisdexamfetamine (LDX), and methylphenidate (MPH), as the …